A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
Clinical trial NCT07645248 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07645248
- Sponsor
- GlaxoSmithKline
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-15
- Primary completion
- 2027-02-25
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.